Both can be characterized by cognitive impairment, neuronal damage, neuroinflammation, progressive neurovascular dysfunction, disruption of the blood–brain barrier (BBB), metabolic disorders, and the accumulation of harmful substances of pathological proteins like β-amyloid and phosphorylated tau. The gene discussed is MAPT; the disease is Cognitive impairment.